Voting after Friday’s conference, the Supreme Court followed the Solicitor General’s advice and denied certiorari in Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc. (No. 18-817), but also denied cert. in Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC (No. 19-430), and HP Inc. v. Berkheimer (No. 18-415).
Perhaps the Court has decided its work with 35 USC § 101 is done, and the rest is up to Congress.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.